Hepatitis B Virus in Oocytes and Embryos: Pregnancy Outcomes and Children’s Health

Xiaoling Hu,Yingzhi Yang,Guofang Feng,Xiaoqian Zhou,Minyue Tang,Huanmiao Yan,Miao Li,Aixia Liu,Yimin Zhu
DOI: https://doi.org/10.1016/j.xfre.2024.07.002
2024-01-01
F&S Reports
Abstract:Objective To investigate whether the presence of hepatitis B virus (HBV) in oocytes and embryos affects pregnancy outcomes for in vitro fertilization and embryo transfer (IVF-ET) and is related to the vertical transmission of HBV to children. Design Retrospective cohort study. Setting A university-affiliated fertility center. Patient(s) This study included 167 couples with at least one HBsAg-seropositive partner. These couples underwent IVF-ET and the discarded oocytes and embryos had been tested for HBV. Couples with HBV-positive oocytes or embryos were categorized as the positive group, whereas those couples with HBV-negative oocytes and embryos served as the negative group. Intervention(s) None. Main Outcome Measure(s) Pregnancy outcomes and the rate of children’s HBV infected. Result(s) The pregnancy outcomes of fresh and frozen ET were not associated with the presence of HBV in the oocytes and embryos. Out of the 106 babies born, one child whose mother tested positive for HBsAg but had negative oocytes and embryos was infected with HBV. Additionally, 26.09% children who had been administered passive immunization and active vaccinations did not reach protective levels of anti-HBV antibodies (HBsAb) and became non-responders. The negative rate of children’s HBsAb was associated with the presence of HBV in oocytes and embryos (OR=3.01, 95% CI=1.04-9.25, P < 0.05). Conclusion(s) The presence of HBV in oocytes and embryos did not affect pregnancy outcomes or result in the vertical transmission of HBV to the offspring of HBV carriers. Follow-up is needed for HBV-vaccinated children with an HBV-infected parent. Booster vaccinations are necessary for continued protection.
What problem does this paper attempt to address?